SAN DIEGO, Sep 07, 2011 (BUSINESS WIRE) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentations at two upcoming investment conferences.
Illumina will webcast its presentation at the Morgan Stanley Global Healthcare Conference in New York, New York, on September 13, 2011. The live webcast is scheduled to begin at 8:35 a.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session.
Illumina will also webcast its presentation at the UBS Global Life Sciences Conference in New York, New York, on September 19, 2011. The live webcast is scheduled to begin at 10:00 a.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session.
These webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at http://www.illumina.com.
About Illumina
Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.
SOURCE: Illumina, Inc.
Illumina, Inc.
Investors:
Kevin Williams, MD
Investor Relations
858-332-4989
kwilliams@illumina.com
or
Media:
Laura Trotter
Public Relations
858-882-6822
PR@illumina.com
